

No data available
No data available
No data available
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total Revenue | 24.64 | 17.88 | 13.90 |
| Total Expenses | 20.44 | 16.76 | 13.60 |
| Profit Before Tax | 4.20 | 1.12 | 0.30 |
| Profit After Tax | 3.10 | 0.80 | 0.19 |
| Operating Profit After Depreciation | 4.66 | 1.36 | 0.44 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Fixed Assets | 0.99 | 0.63 | 0.52 |
| Total Non Current Assets | 2.18 | 1.70 | 0.56 |
| Total Current Assets | 19.74 | 8.32 | 5.65 |
| Total Assets | 21.92 | 10.03 | 6.22 |
| Total Shareholder's Fund | 6.97 | 1.77 | 0.97 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Net Cash From Operating Activities | -1.84 | -2.17 | -0.18 |
| Net Cash Used In Investing Activities | -0.54 | -0.30 | -0.35 |
| Net Cash Used In Financing Activities | 6.68 | 2.86 | 0.81 |
No data available
No data available
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
No data available
On 10 November 2025
03 Nov 2025, 09:53 am
Shares of Aptus Pharma was trading at Rs 84 on the BSE, a premium of 20% compared with the issue price of Rs 70.
30 Sep 2025, 01:57 pm
30 Sep 2025, 09:25 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.